Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014

S. A. McNeil; V. Shinde; M. Andrew; T. F. Hatchette; J. Leblanc; A. Ambrose; G. Boivin; W. R. Bowie; F. Diaz-Mitoma; M. ElSherif; K. Green; F. Haguinet; S. Halperin; B. Ibarguchi; K. Katz; J. M. Langley; P. Lagacã-Wiens; B. Light; M. Loeb; J. McElhaney; D. MacKinnon-Cameron; A. E. McCarthy; M. Poirier; J. Powis; D. Richardson; M. Semret; S. Smith; D. Smyth; G. Stiver; S. Trottier; L. Valiquette; D. Webster; L. Ye; A. McGeer

doi:10.2807/1560-7917.ES2014.19.9.20729

Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014

S. A. McNeil, V. Shinde, M. Andrew, T. F. Hatchette, J. Leblanc, A. Ambrose, G. Boivin, W. R. Bowie, F. Diaz-Mitoma, M. ElSherif, K. Green, F. Haguinet, S. Halperin, B. Ibarguchi, K. Katz, J. M. Langley, P. Lagacã-Wiens, B. Light, M. Loeb, J. McElhaneyD. MacKinnon-Cameron, A. E. McCarthy, M. Poirier, J. Powis, D. Richardson, M. Semret, S. Smith, D. Smyth, G. Stiver, S. Trottier, L. Valiquette, D. Webster, L. Ye, A. McGeer

Medicine

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

39 Citas (Scopus)

Resumen

During the 2013/14 influenza season in Canada, 631 of 654 hospitalisations for laboratory-confirmed influenza enrolled in sentinel hospitals were due to Influenza A. Of the 375 with known subtype, influenza A(H1N1) accounted for 357. Interim unmatched vaccine effectiveness adjusted for age and presence of one or more medical comorbidities was determined by test-negative case-control design to be 58.5% (90% confidence interval (CI): 43.9-69.3%) overall and 57.9% (90% CI: 37.7-71.5) for confirmed influenza A(H1N1).

Idioma original	English
Publicación	Eurosurveillance
Volumen	19
N.º	9
DOI	https://doi.org/10.2807/1560-7917.ES2014.19.9.20729
Estado	Published - 2014

ASJC Scopus Subject Areas

Epidemiology
Public Health, Environmental and Occupational Health
Virology

PubMed: MeSH publication types

Journal Article
Research Support, Non-U.S. Gov't

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.2807/1560-7917.ES2014.19.9.20729

Otros archivos y enlaces

Citar esto

McNeil, S. A., Shinde, V., Andrew, M., Hatchette, T. F., Leblanc, J., Ambrose, A., Boivin, G., Bowie, W. R., Diaz-Mitoma, F., ElSherif, M., Green, K., Haguinet, F., Halperin, S., Ibarguchi, B., Katz, K., Langley, J. M., Lagacã-Wiens, P., Light, B., Loeb, M., ... McGeer, A. (2014). Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014. Eurosurveillance, 19(9). https://doi.org/10.2807/1560-7917.ES2014.19.9.20729

McNeil, SA, Shinde, V, Andrew, M, Hatchette, TF, Leblanc, J, Ambrose, A, Boivin, G, Bowie, WR, Diaz-Mitoma, F, ElSherif, M, Green, K, Haguinet, F, Halperin, S, Ibarguchi, B, Katz, K, Langley, JM, Lagacã-Wiens, P, Light, B, Loeb, M, McElhaney, J, MacKinnon-Cameron, D, McCarthy, AE, Poirier, M, Powis, J, Richardson, D, Semret, M, Smith, S, Smyth, D, Stiver, G, Trottier, S, Valiquette, L, Webster, D, Ye, L & McGeer, A 2014, 'Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014', Eurosurveillance, vol. 19, n.º 9. https://doi.org/10.2807/1560-7917.ES2014.19.9.20729

@article{05d90bedaeac4469ba1840cd20c884e9,

title = "Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014",

abstract = "During the 2013/14 influenza season in Canada, 631 of 654 hospitalisations for laboratory-confirmed influenza enrolled in sentinel hospitals were due to Influenza A. Of the 375 with known subtype, influenza A(H1N1) accounted for 357. Interim unmatched vaccine effectiveness adjusted for age and presence of one or more medical comorbidities was determined by test-negative case-control design to be 58.5% (90% confidence interval (CI): 43.9-69.3%) overall and 57.9% (90% CI: 37.7-71.5) for confirmed influenza A(H1N1).",

author = "McNeil, {S. A.} and V. Shinde and M. Andrew and Hatchette, {T. F.} and J. Leblanc and A. Ambrose and G. Boivin and Bowie, {W. R.} and F. Diaz-Mitoma and M. ElSherif and K. Green and F. Haguinet and S. Halperin and B. Ibarguchi and K. Katz and Langley, {J. M.} and P. Lagac{\~a}-Wiens and B. Light and M. Loeb and J. McElhaney and D. MacKinnon-Cameron and McCarthy, {A. E.} and M. Poirier and J. Powis and D. Richardson and M. Semret and S. Smith and D. Smyth and G. Stiver and S. Trottier and L. Valiquette and D. Webster and L. Ye and A. McGeer",

year = "2014",

doi = "10.2807/1560-7917.ES2014.19.9.20729",

language = "English",

volume = "19",

journal = "Eurosurveillance",

issn = "1025-496X",

publisher = "Centre Europeen pour la Surveillance Epidemiologique du SIDA",

number = "9",

}

TY - JOUR

T1 - Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014

AU - McNeil, S. A.

AU - Shinde, V.

AU - Andrew, M.

AU - Hatchette, T. F.

AU - Leblanc, J.

AU - Ambrose, A.

AU - Boivin, G.

AU - Bowie, W. R.

AU - Diaz-Mitoma, F.

AU - ElSherif, M.

AU - Green, K.

AU - Haguinet, F.

AU - Halperin, S.

AU - Ibarguchi, B.

AU - Katz, K.

AU - Langley, J. M.

AU - Lagacã-Wiens, P.

AU - Light, B.

AU - Loeb, M.

AU - McElhaney, J.

AU - MacKinnon-Cameron, D.

AU - McCarthy, A. E.

AU - Poirier, M.

AU - Powis, J.

AU - Richardson, D.

AU - Semret, M.

AU - Smith, S.

AU - Smyth, D.

AU - Stiver, G.

AU - Trottier, S.

AU - Valiquette, L.

AU - Webster, D.

AU - Ye, L.

AU - McGeer, A.

PY - 2014

Y1 - 2014

N2 - During the 2013/14 influenza season in Canada, 631 of 654 hospitalisations for laboratory-confirmed influenza enrolled in sentinel hospitals were due to Influenza A. Of the 375 with known subtype, influenza A(H1N1) accounted for 357. Interim unmatched vaccine effectiveness adjusted for age and presence of one or more medical comorbidities was determined by test-negative case-control design to be 58.5% (90% confidence interval (CI): 43.9-69.3%) overall and 57.9% (90% CI: 37.7-71.5) for confirmed influenza A(H1N1).

AB - During the 2013/14 influenza season in Canada, 631 of 654 hospitalisations for laboratory-confirmed influenza enrolled in sentinel hospitals were due to Influenza A. Of the 375 with known subtype, influenza A(H1N1) accounted for 357. Interim unmatched vaccine effectiveness adjusted for age and presence of one or more medical comorbidities was determined by test-negative case-control design to be 58.5% (90% confidence interval (CI): 43.9-69.3%) overall and 57.9% (90% CI: 37.7-71.5) for confirmed influenza A(H1N1).

UR - http://www.scopus.com/inward/record.url?scp=84896901087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896901087&partnerID=8YFLogxK

U2 - 10.2807/1560-7917.ES2014.19.9.20729

DO - 10.2807/1560-7917.ES2014.19.9.20729

M3 - Article

C2 - 24626207

AN - SCOPUS:84896901087

SN - 1025-496X

VL - 19

JO - Eurosurveillance

JF - Eurosurveillance

IS - 9

ER -

Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014

Resumen

ASJC Scopus Subject Areas

PubMed: MeSH publication types

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto